Delivery details +
Order by fax
MAP Pharmaceuticals - Pharmaceuticals & Healthcare
- PDF: Delivered by email usually within 12 to 24 UK business hours.
MAP Pharmaceuticals - Pharmaceuticals & Healthcare
Deals and Alliances Profile
- Product Code:GMD10668
- Publication Date:July 2009
- Publisher:Global Markets Direct
- Product Type: Report
- Pages:19
MAP Pharmaceuticals - Pharmaceuticals & Healthcare Deals and Alliances Profile
MAP Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
MAP Pharmaceuticals, Inc., (MAP) is a development stage company, engaged in developing drug candidates to treat local respiratory and treatable diseases. The company also develops inhalable drug particles to facilitate pulmonary delivery. The company's proprietary product candidate is Unit Dose Budesonide, a nebulized version of budesonide for the treatment of pediatric asthma in children. The company is headquartered at Mountain View in California, United States
Global Market Direct's MAP Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
MAP Pharmaceuticals, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deal Details 9
Equity Offering 9
Map Pharmaceuticals Files Registration Statement For Public Offering Of $100 Million 9
MAP Pharmaceuticals Completes Initial Public Offering Of $69 Million 10
Partnerships 11
MAP Pharmaceuticals Signs Agreement With AstraZeneca 11
MAP Pharmaceuticals Signs Agreement With Telesso Technologies 12
MAP Pharmaceuticals Signs Agreement With Eiffel Technologies 13
MAP Pharmaceuticals Extends Agreement With Elan 14
Venture Financing 15
MAP Pharmaceuticals Secures $50 Million In Series D Financing 15
MAP Pharmaceuticals Secures $25.25 Million In Series C Financing 16
MAP Pharmaceuticals Secures $30 Million In Series B Financing 17
Key Competitors 18
Key Employees 18
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About Global Markets Direct 19
Contact Us 19
Disclaimer 19
List of Tables
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
MAP Pharmaceuticals, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
MAP Pharmaceuticals, Deals By Sector, 2004 to YTD 2009 7
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Map Pharmaceuticals Files Registration Statement For Public Offering Of $100 Million 9
MAP Pharmaceuticals Completes Initial Public Offering Of $69 Million 10
MAP Pharmaceuticals Signs Agreement With AstraZeneca 11
MAP Pharmaceuticals Signs Agreement With Telesso Technologies 12
MAP Pharmaceuticals Signs Agreement With Eiffel Technologies 13
MAP Pharmaceuticals Extends Agreement With Elan 14
MAP Pharmaceuticals Secures $50 Million In Series D Financing 15
MAP Pharmaceuticals Secures $25.25 Million In Series C Financing 16
MAP Pharmaceuticals Secures $30 Million In Series B Financing 17
MAP Pharmaceuticals, Key Employees 18
List of Figures
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
MAP Pharmaceuticals, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
